Apolipoprotein Mimetic Peptides: Potential New Therapies for Cardiovascular Diseases

Apolipoprotein Mimetic Peptides: Potential New Therapies for Cardiovascular Diseases

Since the seminal breakthrough of treating diabetic patients with insulin in the 1920s, there has been great interest in developing other proteins and their peptide mimetics as therapies for a wide variety of other medical disorders. Currently, there are at least 60 different peptides that have been...

Full description

Bibliographic Details
Main Authors:	Anna Wolska, Mart Reimund, Denis O. Sviridov, Marcelo J. Amar, Alan T. Remaley
Format:	Article
Language:	English
Published:	MDPI AG 2021-03-01
Series:	Cells
Subjects:	apolipoprotein atherosclerosis cardiovascular diseases cholesterol clinical trials HDL
Online Access:	https://www.mdpi.com/2073-4409/10/3/597

Similar Items

A Systematic Review of Apolipoprotein A-I Mimetic Peptides for Atherosclerosis Therapy via Activation of Reverse Cholesterol Transport Pathway
by: Aiman Asaduddin, et al.
Published: (2022-11-01)

A novel method for oral delivery of apolipoprotein mimetic peptides synthesized from all L-amino acids
by: Mohamad Navab, et al.
Published: (2009-08-01)

Safety, pharmacokinetics, and pharmacodynamics of oral apoA-I mimetic peptide D-4F in high-risk cardiovascular patients*
by: LeAnne T. Bloedon, et al.
Published: (2008-06-01)

NON-CLINICAL DEVELOPMENT OF CER-001
by: Ronald eBarbaras
Published: (2015-10-01)

Cholesterol–sphingomyelin interaction in membrane and apolipoprotein-mediated cellular cholesterol efflux
by: Jin-ichi Ito, et al.
Published: (2000-06-01)

Apolipoprotein Mimetic Peptides: A New Approach for the Treatment of Asthma
by: Xianglan eYao, et al.
Published: (2012-03-01)

Apolipoprotein A-II, a Player in Multiple Processes and Diseases
by: Gabriela Florea, et al.
Published: (2022-07-01)

Plasma proteoforms of apolipoproteins C-I and C-II are associated with plasma lipids in the Multi-Ethnic Study of Atherosclerosis
by: Juraj Koska, et al.
Published: (2022-09-01)

Subcutaneous Administration of Apolipoprotein J-Derived Mimetic Peptide <span style="font-variant: small-caps">d</span>-[113–122]apoJ Improves LDL and HDL Function and Prevents Atherosclerosis in LDLR-KO Mice
by: Andrea Rivas-Urbina, et al.
Published: (2020-05-01)

Storage of human plasma samples leads to alterations in the lipoprotein distribution of apoC-III and apoE
by: Jeffrey S. Cohn, et al.
Published: (2004-08-01)

Apolipoprotein A1 and high-density lipoprotein limit low-density lipoprotein transcytosis by binding SR-B1
by: Karen Y.Y. Fung, et al.
Published: (2024-04-01)

Apolipoprotein A-I: structure–function relationships
by: Philippe G. Frank, et al.
Published: (2000-06-01)

Non-HDL cholesterol: A valid surrogate marker to apolipoprotein b100 in type 2 diabetes mellitus patients in assessment of risk of cardiovascular diseases
by: Vidyashree, et al.
Published: (2024-07-01)

Evaluating the relation between serum apolipoprotein B (apo B), apolipoprotein A (apo A) and apo B/apo A ratio with diabetic retinopathy in a sample of type 2 Egyptian diabetic patient
by: Salwa Seddik Hosny, et al.
Published: (2023-08-01)

Pro- or anti-inflammatory role of apolipoprotein A-1 in high-density lipoproteins?
by: Nicolas Vuilleumier, et al.
Published: (2013-05-01)

Efficacy and Safety of High-Density Lipoprotein/Apolipoprotein A1 Replacement Therapy in Humans and Mice With Atherosclerosis: A Systematic Review and Meta-Analysis
by: Ayiguli Abudukeremu, et al.
Published: (2021-08-01)

Apolipoprotein and lipid abnormalities in chronic liver failure
by: A.C. Spósito, et al.
Published: (1997-11-01)

Severely altered cholesterol homeostasis in macrophages lacking apoE and SR-BI
by: Patricia G. Yancey, et al.
Published: (2007-05-01)

Admission levels of high-density lipoprotein and apolipoprotein A-1 are associated with the neurologic outcome in patients with out-of-hospital cardiac arrest
by: Yong Soo Son, et al.
Published: (2017-12-01)

Association of human apolipoprotein E with lipoproteins secreted by transfected McA RH7777 cells
by: Catherine A. Reardon, et al.
Published: (1998-07-01)

Genetically modified mice for the study of apolipoprotein B
by: Edward Kim, et al.
Published: (1998-04-01)

Characterization and quantification of serum lipoprotein subfractions by capillary isotachophoresis: relationships with lipid, apolipoprotein, and lipoprotein levels
by: Alexandra Schlenck, et al.
Published: (1999-11-01)

Pioglitazone increases apolipoprotein A-I production by directly enhancing PPRE-dependent transcription in HepG2 cells
by: Lin-Hua Zhang, et al.
Published: (2010-08-01)

Apolipoprotein A-I promotes cholesterol release and apolipoprotein E recruitment from THP-1 macrophage-like foam cells
by: John K. Bielicki, et al.
Published: (1999-01-01)

Apolipoprotein A-I mimetic peptide 4F blocks sphingomyelinase-induced LDL aggregation
by: Su Duy Nguyen, et al.
Published: (2015-06-01)

Lower HDL-C and apolipoprotein A-I are related to higher glomerular filtration rate in subjects without kidney disease[S]
by: Jan A. Krikken, et al.
Published: (2010-07-01)

HDL in Atherosclerotic Cardiovascular Disease: In Search of a Role
by: Manuela Casula, et al.
Published: (2021-07-01)

Emerging evidences for the opposite role of apolipoprotein C3 and apolipoprotein A5 in lipid metabolism and coronary artery disease
by: Wen Dai, et al.
Published: (2019-12-01)

Assessing High-Density Lipoprotein: Shifting Focus from Quantity to Quality in Cardiovascular Disease Risk Assessment
by: Tanvir Ahmed, et al.
Published: (2024-06-01)

The recycling of apolipoprotein E in macrophages
by: Alyssa H. Hasty, et al.
Published: (2005-07-01)

Apolipoprotein E Deficiency Increases Remnant Lipoproteins and Accelerates Progressive Atherosclerosis, But Not Xanthoma Formation, in Gene-Modified Minipigs
by: Jeong Shim, MD, et al.
Published: (2017-10-01)

Role of LCAT in HDL remodeling: investigation of LCAT deficiency states
by: Bela F. Asztalos, et al.
Published: (2007-03-01)

Will Lipidation of ApoA1 through Interaction with ABCA1 at the Intestinal Level Affect the Protective Functions of HDL?
by: Eric J. Niesor
Published: (2015-01-01)

Comprehensive evaluation of apolipoprotein H gene (APOH) variation identifies novel associations with measures of lipid metabolism in GENOA*s⃞
by: Magalie S. Leduc, et al.
Published: (2008-12-01)

Structure dynamics of ApoA-I amyloidogenic variants in small HDL increase their ability to mediate cholesterol efflux
by: Oktawia Nilsson, et al.
Published: (2021-01-01)

The LDL Apolipoprotein B-to-LDL Cholesterol Ratio: Association with Cardiovascular Mortality and a Biomarker of Small, Dense LDLs
by: Günther Silbernagel, et al.
Published: (2022-06-01)

Functional diversity of high-density lipoproteins: finding the golden mean
by: V. A. Metelskaya
Published: (2021-06-01)

Triglyceride to high-density lipoprotein cholesterol and low-density lipoprotein cholestrol to high-density lipoprotein cholesterol ratios are predictors of cardiovascular risk in Iranian adults: Evidence from a population-based cross-sectional study
by: Karimollah Hajian-Tilaki, et al.
Published: (2020-01-01)

Unusual Mild Phenotype Presentation in an Elderly Patient with Homozygous Tangier Disease
by: Ornella Guardamagna, et al.
Published: (2024-10-01)

Effect of Lactobacillus delbrueckii on cholesterol metabolism in germ-free mice and on atherogenesis in apolipoprotein E knock-out mice
by: L.R. Portugal, et al.
Published: (2006-05-01)